Dr Shreekant Sambrani pays tribute to M S Swaminathan, renowned agricultural scientist and a lifelong crusader against hunger who passed away in Chennai recently.
Applications are invited for admissions to the five and a half year, Bachelor Degree Course (BHMS) in homoeopathy at the National Institute of Homoeopathy, Kolkata.
I suggest we build a Vigyan Mandir (Temple of Science) with the ambience of a place of worship, so that it becomes a destination for pilgrims. We should embed on its walls bronze plaques describing each scientist mentioned here along with about a dozen of our ancient mathematicians, recommends Professor Kalyan Singhal, historian of science and technology.
Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, minister of state for health Ashwini Choubey informed the Rajya Sabha on Tuesday.
Wang Guangfa, a respiratory expert from Peking University First Hospital, warned that Beijing may experience a spike in severe COVID-19 cases over the next fortnight.
'You are dealing with a small gang of semi-literate terrorists. These are guys flying kites.' 'There is huge difference between flying kites and actually having a deliverable, executable, plan.'
For the first time in Tamil Nadu, a lion has died of coronavirus while nine others in the pride have tested positive for the infection at a zoo near Chennai, an official said.
Health Minister Harsh Vardhan said the COVID-19 vaccine will be available in the next few months and it is estimated that by July-August 400-500 million doses will be made available for 25-30 crore people.
The official expressed hope on the success of the five vaccines that are under different phases of trial in the country.
While there has been no commitment from the government on the procurement of vaccines, initial volumes, or distribution plans, there is a likelihood that the low interest loans may be made available to these players only when the time to scale up manufacturing arises.
The B.1.617 variant of SARS-CoV2, also being called a 'double mutant' or the 'Indian strain', has been found prevalent largely in Maharashtra and Delhi that have been severely hit by a devastating second wave of the pandemic.
As India prepares to launch its vaccine drive on January 16, here is a look at the options:
The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments available in India to 12.
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
As concerns mounted and some people wondered whether this could possibly turn out to be another Covid, pulmonologist Anurag Agrawal said he doesn't expect to see a massive wave.
a team led by ecologist Uma Ramakrishnan and her student Vinay Sagar from the National Centre for Biological Sciences, Bangalore, have discovered that the coat colouration and patterning which make the wild cats appear dark boil down to a single mutation
'Everybody says 5G and communication is important.' 'Everybody says automation, robotics, human computing interfaces -- people and machines working together -- is the future.' 'Everybody agrees that cybersecurity is something that is here to stay.' 'Everybody agrees that synthetic biology is important.' 'Instead of outlining thinking about industries for tomorrow and the future, let the evolutionary pathway be built in a way that it promotes robust, creative, thinking.'
China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the United States drug regulator on Sunday.
According to an official statement, the FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA).
Confirming the Drugs Controller General Of India (DCGI) approval, Serum Institute of India CEO Adar Poonawalla on Tuesday tweeted: '@SerumInstIndia's brand Covovax has completed bridging studies in India and has been granted Emergency Use Authorisation by DCGI for adults and for children above the age of 12. Younger age groups will follow shortly.'
A case of COVID-19 had been reported from the building situated in 'theke wali gali' on April 18, prompting authorities to timely seal it. This helped in containing the spread of coronavirus in the area. The administration will conduct tests of people residing in the building on Sunday again.
Asked why the United States was targeting Putin's daughters, a senior Biden administration official said the US thought they could be in control of some of their father's assets.
The international team of researchers combined lab-based experiments and epidemiology of vaccine breakthrough infections, showing that the Delta variant is better at replicating and spreading than other commonly-observed variants.
As the Omicron strain spreads across the globe and questions on vaccine inequity dominate discussions, scientists are still scrambling to learn more about emerging variants of the deadly virus that has claimed millions of lives and crippled economies.
A bench headed by Justice Ashok Bhushan and comprising justices R S Reddy and M R Shah said that voluntary contribution can always be made to the NDRF as there is no statutory bar under the Disaster Management Act.
The results of the assembly elections in Gujarat and Himachal Pradesh are likely to play out during the winter session of Parliament beginning Wednesday.
This test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of SARS-CoV-2 virus, CSIR said in a statement.
Chandrayaan-II hard-landed on lunar surface last year. The Indian Space Research Organisation had then resolved to launch the project again. It had said the project is likely to be launched by the end of the year.
Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.
More than 2 million people have been diagnosed with coronavirus across the world, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global pandemic. According to the World Health Organization, there are now more than 70 potential vaccines under evelopment, with some already in clinical trials.
All these persons have been kept in single room isolation at designated health care facilities by respective state governments and their close contacts have also been put under quarantine, the ministry said.
The female tiger, named Nadia, is believed to be the first known case of an animal infected with COVID-19 in the US. It is suspected that she contracted the virus from a caretaker who was asymptomatic at that time.
To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.
"The concrete actions are a stern indication that Government of India is making all out efforts to increase vaccine production in the country as well as attracting foreign vaccine manufacturers to supply the required vaccine doses for national Covid vaccination programme," the ministry in a statement.
'Wearing masks, washing our hands, all those things are barriers to transmissibility, or contagion, but as the virus becomes more contagious it statistically is better at getting around those barriers'
Did you know that ethical hackers earn anything between Rs 800 to Rs 1,000 per hour?
Scientists around the world, including in India, suggest it hasn't been tested properly given the time constraint and there may not be enough evidence to prove its efficacy.
While some researchers are developing prototypes for ventilators to overcome their shortage, others have teamed up to develop testing kits.
The prime minister was happy that the assurance given by the Serum Institute that it will make India self-sufficient in vaccines at the lowest possible price in the world was fulfilled.
According to the World Health Organisation, 10 candidate vaccines for COVID-19 are in the clinical evaluation and 126 are in the pre-clinical stage.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances